NO992340L - Faste farmas°ytiske blandinger omfattende et cyklosporin og et anionisk overflateaktivt middel - Google Patents

Faste farmas°ytiske blandinger omfattende et cyklosporin og et anionisk overflateaktivt middel

Info

Publication number: NO992340L
Authority: NO; Norway
Prior art keywords: cyclosporin; anionic surfactant; solid pharmaceutical; pharmaceutical compositions; disclosed
Prior art date: 1997-09-16

Application number

NO992340A

Other languages

English (en)

Norwegian (no)

Other versions

NO992340D0 (no

Inventor

Bernard Charles Sherman

Original Assignee

Bernard Charles Sherman

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-09-16

Filing date

1999-05-14

Publication date

1999-07-06

1999-05-14 Application filed by Bernard Charles Sherman filed Critical Bernard Charles Sherman

1999-05-14 Publication of NO992340D0 publication Critical patent/NO992340D0/no

1999-07-06 Publication of NO992340L publication Critical patent/NO992340L/no

Links

PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 title abstract 2
229930105110 Cyclosporin A Natural products 0.000 title abstract 2
108010036949 Cyclosporine Proteins 0.000 title abstract 2
239000003945 anionic surfactant Substances 0.000 title abstract 2
229960001265 ciclosporin Drugs 0.000 title abstract 2
229930182912 cyclosporin Natural products 0.000 title abstract 2
239000008194 pharmaceutical composition Substances 0.000 title abstract 2
239000007787 solid Substances 0.000 title abstract 2
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 abstract 1
235000019333 sodium laurylsulphate Nutrition 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Immunology (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Transplantation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)

NO992340A 1997-09-16 1999-05-14 Faste farmas°ytiske blandinger omfattende et cyklosporin og et anionisk overflateaktivt middel NO992340L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
NZ328751A NZ328751A (en)	1997-09-16	1997-09-16	Solid medicament containing an anionic surfactant and cyclosporin
PCT/CA1998/000880 WO1999013900A1 (en)	1997-09-16	1998-09-16	Solid pharmaceutical compositions comprising a cyclosporin and an anionic surfactant

Publications (2)

Publication Number	Publication Date
NO992340D0 NO992340D0 (no)	1999-05-14
NO992340L true NO992340L (no)	1999-07-06

Family

ID=19926445

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO992340A NO992340L (no)	1997-09-16	1999-05-14	Faste farmas°ytiske blandinger omfattende et cyklosporin og et anionisk overflateaktivt middel

Country Status (23)

Country	Link
US (1)	US6197335B1 (de)
EP (1)	EP0957931B1 (de)
JP (1)	JP2001505928A (de)
KR (1)	KR20000068991A (de)
CN (1)	CN1239432A (de)
AR (1)	AR013499A1 (de)
AT (1)	ATE214938T1 (de)
AU (1)	AU9149198A (de)
BR (1)	BR9806212A (de)
CA (1)	CA2271447A1 (de)
CZ (1)	CZ157099A3 (de)
DE (1)	DE69804429D1 (de)
HU (1)	HUP0000839A3 (de)
ID (1)	ID21683A (de)
IL (1)	IL129780A0 (de)
NO (1)	NO992340L (de)
NZ (1)	NZ328751A (de)
PL (1)	PL333353A1 (de)
SI (1)	SI9820010A (de)
TR (1)	TR199901070T1 (de)
WO (1)	WO1999013900A1 (de)
YU (1)	YU22399A (de)
ZA (1)	ZA988452B (de)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5858401A (en)	1996-01-22	1999-01-12	Sidmak Laboratories, Inc.	Pharmaceutical composition for cyclosporines
US7732404B2 (en) *	1999-12-30	2010-06-08	Dexcel Ltd	Pro-nanodispersion for the delivery of cyclosporin
GB0008785D0 (en) *	2000-04-10	2000-05-31	Novartis Ag	Organic compounds
AR033711A1 (es) *	2001-05-09	2004-01-07	Novartis Ag	Composiciones farmaceuticas
EP1435910B9 (de) *	2001-10-19	2010-02-03	Isotechnika Inc.	Neue cyclosporin-analoge mikroemulsionsvorkonzentrate
US20060078893A1 (en)	2004-10-12	2006-04-13	Medical Research Council	Compartmentalised combinatorial chemistry by microfluidic control
GB0307428D0 (en)	2003-03-31	2003-05-07	Medical Res Council	Compartmentalised combinatorial chemistry
GB0307403D0 (en)	2003-03-31	2003-05-07	Medical Res Council	Selection by compartmentalised screening
US20050059583A1 (en)	2003-09-15	2005-03-17	Allergan, Inc.	Methods of providing therapeutic effects using cyclosporin components
JP4521554B2 (ja) *	2004-03-31	2010-08-11	マイラン製薬株式会社	シクロスポリン製剤
US20050221339A1 (en)	2004-03-31	2005-10-06	Medical Research Council Harvard University	Compartmentalised screening by microfluidic control
US7968287B2 (en)	2004-10-08	2011-06-28	Medical Research Council Harvard University	In vitro evolution in microfluidic systems
US7297679B2 (en) *	2005-07-13	2007-11-20	Allergan, Inc.	Cyclosporin compositions
US20070015691A1 (en) *	2005-07-13	2007-01-18	Allergan, Inc.	Cyclosporin compositions
US7202209B2 (en)	2005-07-13	2007-04-10	Allergan, Inc.	Cyclosporin compositions
US7276476B2 (en) *	2005-07-13	2007-10-02	Allergan, Inc.	Cyclosporin compositions
US7288520B2 (en) *	2005-07-13	2007-10-30	Allergan, Inc.	Cyclosporin compositions
US20070015693A1 (en) *	2005-07-13	2007-01-18	Allergan, Inc.	Cyclosporin compositions
US7501393B2 (en)	2005-07-27	2009-03-10	Allergan, Inc.	Pharmaceutical compositions comprising cyclosporins
US9839667B2 (en)	2005-10-14	2017-12-12	Allergan, Inc.	Prevention and treatment of ocular side effects with a cyclosporin
US7745400B2 (en) *	2005-10-14	2010-06-29	Gregg Feinerman	Prevention and treatment of ocular side effects with a cyclosporin
WO2007081385A2 (en)	2006-01-11	2007-07-19	Raindance Technologies, Inc.	Microfluidic devices and methods of use in the formation and control of nanoreactors
US9562837B2 (en)	2006-05-11	2017-02-07	Raindance Technologies, Inc.	Systems for handling microfludic droplets
WO2007133710A2 (en)	2006-05-11	2007-11-22	Raindance Technologies, Inc.	Microfluidic devices and methods of use thereof
US9012390B2 (en)	2006-08-07	2015-04-21	Raindance Technologies, Inc.	Fluorocarbon emulsion stabilizing surfactants
WO2008097559A2 (en)	2007-02-06	2008-08-14	Brandeis University	Manipulation of fluids and reactions in microfluidic systems
WO2008130623A1 (en)	2007-04-19	2008-10-30	Brandeis University	Manipulation of fluids, fluid components and reactions in microfluidic systems
SG2013054218A (en)	2008-01-15	2014-10-30	Abbott Gmbh & Co Kg	Powdered protein compositions and methods of making same
CA2716082A1 (en) *	2008-03-04	2009-02-23	F. Hoffmann-La Roche Ag	Process for preparing concentrated aqueous micellar solutions
EP4047367A1 (de)	2008-07-18	2022-08-24	Bio-Rad Laboratories, Inc.	Verfahren zum nachweis von zielanalyten unter verwendung von tropfenbibliotheken
US12038438B2 (en)	2008-07-18	2024-07-16	Bio-Rad Laboratories, Inc.	Enzyme quantification
WO2010111231A1 (en)	2009-03-23	2010-09-30	Raindance Technologies, Inc.	Manipulation of microfluidic droplets
US10520500B2 (en)	2009-10-09	2019-12-31	Abdeslam El Harrak	Labelled silica-based nanomaterial with enhanced properties and uses thereof
EP2517025B1 (de)	2009-12-23	2019-11-27	Bio-Rad Laboratories, Inc.	Verfahren zur reduzierung des austauschs von molekülen zwischen tröpfchen
US9366632B2 (en)	2010-02-12	2016-06-14	Raindance Technologies, Inc.	Digital analyte analysis
US9399797B2 (en)	2010-02-12	2016-07-26	Raindance Technologies, Inc.	Digital analyte analysis
EP4435111A1 (de)	2010-02-12	2024-09-25	Bio-Rad Laboratories, Inc.	Digitale analytanalyse
US10351905B2 (en)	2010-02-12	2019-07-16	Bio-Rad Laboratories, Inc.	Digital analyte analysis
WO2012045012A2 (en)	2010-09-30	2012-04-05	Raindance Technologies, Inc.	Sandwich assays in droplets
EP3859011A1 (de)	2011-02-11	2021-08-04	Bio-Rad Laboratories, Inc.	Verfahren zur bildung gemischter tröpfchen
WO2012112804A1 (en)	2011-02-18	2012-08-23	Raindance Technoligies, Inc.	Compositions and methods for molecular labeling
US8841071B2 (en)	2011-06-02	2014-09-23	Raindance Technologies, Inc.	Sample multiplexing
EP2714970B1 (de)	2011-06-02	2017-04-19	Raindance Technologies, Inc.	Enzymquantifizierung
US8658430B2 (en)	2011-07-20	2014-02-25	Raindance Technologies, Inc.	Manipulating droplet size
US11901041B2 (en)	2013-10-04	2024-02-13	Bio-Rad Laboratories, Inc.	Digital analysis of nucleic acid modification
US9944977B2 (en)	2013-12-12	2018-04-17	Raindance Technologies, Inc.	Distinguishing rare variations in a nucleic acid sequence from a sample
WO2015103367A1 (en)	2013-12-31	2015-07-09	Raindance Technologies, Inc.	System and method for detection of rna species
BR112016015766A2 (pt)	2014-01-06	2017-08-08	Iron Therapeutics Holdings Ag	Regime de dosagem de trimaltol férrico
GB201418710D0 (en)	2014-10-21	2014-12-03	Iron Therapeutics Holdings Ag	Dosage regimen
US10647981B1 (en)	2015-09-08	2020-05-12	Bio-Rad Laboratories, Inc.	Nucleic acid library generation methods and compositions
US11833151B2 (en) *	2018-03-19	2023-12-05	Taiho Pharmaceutical Co., Ltd.	Pharmaceutical composition including sodium alkyl sulfate
MX2023002660A (es) *	2020-09-17	2023-03-28	Catalent Uk Swindon Zydis Ltd	Uso de tensioactivo con formulaciones de dosificacion a base de gelatina de pescado de alto peso molecular para mejorar caracteristicas de flujo.
US20250302912A1 (en) *	2021-10-13	2025-10-02	Chugai Seiyaku Kabushiki Kaisha	Composition including peptide compound and surfactant
WO2023214509A1 (ja) *	2022-05-02	2023-11-09	中外製薬株式会社	界面活性剤と併用するためのペプチド化合物を含む組成物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL7908722A (nl)	1979-12-03	1981-07-01	Naarden International Nv	Werkwijze voor de bereiding van citrussap bevattende dranken met verbeterde troebelingsstabiliteit.
US5639724A (en) *	1984-07-24	1997-06-17	Sandoz Ltd.	Cyclosporin galenic forms
JP2577049B2 (ja)	1987-06-04	1997-01-29	三共株式会社	シクロスポリン製剤
US5756450A (en) *	1987-09-15	1998-05-26	Novartis Corporation	Water soluble monoesters as solubilisers for pharmacologically active compounds and pharmaceutical excipients and novel cyclosporin galenic forms
US5342625A (en)	1988-09-16	1994-08-30	Sandoz Ltd.	Pharmaceutical compositions comprising cyclosporins
BE1003009A5 (fr) *	1989-02-09	1991-10-22	Sandoz Sa	Nouvelles compositions pharmaceutiques a base de cyclosporines.
DD298351A5 (de) *	1989-11-06	1992-02-20	Jenapharm Gmbh,De	Verfahren zur herstellung einer carrierabhaengigen arzneiform
JPH0597697A (ja) *	1991-10-02	1993-04-20	Lion Corp	歯槽骨再生剤
US5603955A (en) *	1994-07-18	1997-02-18	University Of Cincinnati	Enhanced loading of solutes into polymer gels
IL116674A (en) *	1995-01-09	2003-05-29	Mendell Co Inc Edward	Microcrystalline cellulose-based excipient having improved compressibility, pharmaceutical compositions containing the same and methods for the preparation of said excipient and of solid dosage form thereof
US5573783A (en) *	1995-02-13	1996-11-12	Nano Systems L.L.C.	Redispersible nanoparticulate film matrices with protective overcoats
IE75744B1 (en) *	1995-04-03	1997-09-24	Elan Corp Plc	Controlled release biodegradable micro- and nanospheres containing cyclosporin
IE80467B1 (en) *	1995-07-03	1998-07-29	Elan Corp Plc	Controlled release formulations for poorly soluble drugs
JPH1059862A (ja) *	1996-08-16	1998-03-03	Meiji Seika Kaisha Ltd	シクロスポリン製剤
US5891845A (en) *	1997-11-21	1999-04-06	Fuisz Technologies Ltd.	Drug delivery systems utilizing liquid crystal structures

1997
- 1997-09-16 NZ NZ328751A patent/NZ328751A/xx unknown
1998
- 1998-09-16 EP EP98943603A patent/EP0957931B1/de not_active Expired - Lifetime
- 1998-09-16 BR BR9806212-3A patent/BR9806212A/pt not_active Application Discontinuation
- 1998-09-16 WO PCT/CA1998/000880 patent/WO1999013900A1/en not_active Ceased
- 1998-09-16 AU AU91491/98A patent/AU9149198A/en not_active Abandoned
- 1998-09-16 DE DE69804429T patent/DE69804429D1/de not_active Expired - Lifetime
- 1998-09-16 KR KR1019997004315A patent/KR20000068991A/ko not_active Withdrawn
- 1998-09-16 CN CN98801340A patent/CN1239432A/zh active Pending
- 1998-09-16 HU HU0000839A patent/HUP0000839A3/hu unknown
- 1998-09-16 CA CA002271447A patent/CA2271447A1/en not_active Withdrawn
- 1998-09-16 US US09/308,272 patent/US6197335B1/en not_active Expired - Fee Related
- 1998-09-16 SI SI9820010A patent/SI9820010A/sl unknown
- 1998-09-16 TR TR1999/01070T patent/TR199901070T1/xx unknown
- 1998-09-16 ID IDW990457D patent/ID21683A/id unknown
- 1998-09-16 CZ CZ991570A patent/CZ157099A3/cs unknown
- 1998-09-16 IL IL12978098A patent/IL129780A0/xx unknown
- 1998-09-16 PL PL98333353A patent/PL333353A1/xx not_active Application Discontinuation
- 1998-09-16 AR ARP980104607A patent/AR013499A1/es unknown
- 1998-09-16 AT AT98943603T patent/ATE214938T1/de not_active IP Right Cessation
- 1998-09-16 JP JP51723399A patent/JP2001505928A/ja active Pending
- 1998-09-16 ZA ZA988452A patent/ZA988452B/xx unknown
- 1998-09-16 YU YU22399A patent/YU22399A/sh unknown
1999
- 1999-05-14 NO NO992340A patent/NO992340L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
TR199901070T1 (xx)	1999-11-22
HUP0000839A3 (en)	2001-02-28
CZ157099A3 (cs)	1999-09-15
ZA988452B (en)	1999-03-30
JP2001505928A (ja)	2001-05-08
WO1999013900A1 (en)	1999-03-25
NZ328751A (en)	1999-01-28
US6197335B1 (en)	2001-03-06
HUP0000839A2 (hu)	2000-11-28
DE69804429D1 (de)	2002-05-02
ATE214938T1 (de)	2002-04-15
CA2271447A1 (en)	1999-03-25
KR20000068991A (ko)	2000-11-25
PL333353A1 (en)	1999-12-06
SI9820010A (sl)	1999-08-31
NO992340D0 (no)	1999-05-14
BR9806212A (pt)	2000-04-18
ID21683A (id)	1999-07-08
EP0957931B1 (de)	2002-03-27
CN1239432A (zh)	1999-12-22
EP0957931A1 (de)	1999-11-24
IL129780A0 (en)	2000-02-29
YU22399A (sh)	2003-01-31
AR013499A1 (es)	2000-12-27
AU9149198A (en)	1999-04-05

Legal Events

Date	Code	Title	Description
2001-06-05	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
YU22399A (sh)	2003-01-31	Čvrsti farmaceutski sastavi koji obuhvataju ciklosporin i anjonsko površinski-aktivno sredstvo
LU91122I2 (fr)	2005-01-10	Efalizumab et ses dérivés pharmaceutiquement acceptables (raptiva).
DK0994710T4 (da)	2005-10-17	Farmaceutiske præparater til oral indgivelse omfattende en benzylhydrylpiperazin og en cyclodextrin
NO20083842L (no)	1998-03-23	Anvendelse av opploselig lymfotoksin-beta-reseptor for fremstilling av medikamenter
DK0553191T3 (da)	1995-08-07	Pyridin- og pyridin-N-oxidderivater af diarylmethylpiperidiner eller -piperaziner, præparater og an vendelse deraf
BR0012908A (pt)	2002-04-30	Método para preparar uma composição oral estável antibacteriana contendo uma lupulona hidrogenada, e, composição oral estável antibacteriana
HUT74474A (en)	1996-12-30	Pharmaceutical emulsion comprising a short acting dihydropyridine type antihypertensive agent
AR064896A2 (es)	2009-05-06	Composicion farmaceutica no higroscopica
BR9914251A (pt)	2001-06-19	Formulações orais de liberação sustentada
EE03692B1 (et)	2002-04-15	19-nor-pregneeni derivaadid, mis omavad progestaatilist toimet ja neid sisaldavad farmatseutilised kompositsioonid
MX9505065A (es)	1997-01-31	Composicion farmaceutica, aplicable oralmente.
MX9505064A (es)	1997-01-31	Composicion farmaceutica, aplicable oralmente.
BR9913737A (pt)	2001-06-05	Preparação farmacêutica
MY119722A (en)	2005-07-29	Swallow tablet comprising paracetamol.
DK1119359T3 (da)	2004-08-16	2-methyl-thieno-benzodiazepinformulering
MXPA03005221A (es)	2004-03-26	Composicion farmaceutica de dronedarona para administracion parenteral.
ES2172182T3 (es)	2002-09-16	Composiciones farmaceuticas que comprenden cefuroxima axetil.
TR200000697T2 (tr)	2001-01-22	İkame edilmiş 1,2,3,4,5,6-Heksahidro-2,6-Metano-3-Benzazosin-10-OL'ler, üretim yöntemleri ve farmasötik preparat olarak kullanımları.
PT1107793E (pt)	2005-02-28	Conjugados de dextrano-leptina, composicoes farmaceuticas e processos relacionados
ATE289609T1 (de)	2005-03-15	Makrolid-lhrh-antagonisten
NZ506622A (en)	2003-03-28	3',3'-N-bis-substituted macrolide LHRH antagonists
ES2159260B1 (es)	2002-05-01	Nueva composicion de metanosulfonato de paroxetina
BR0011864A (pt)	2004-07-20	Formulações farmacêuticas
ES2191241T3 (es)	2003-09-01	Preparaciones farmaceuticas por via oral que comprenden s-(3-hidroxipropil)-l-cisteina.
BR0001144B1 (pt)	2013-10-22	Composicão farmacêutica de diclofenaco à base de vitamina-e, papaína e hialuronidase